Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Equity: 2024-2025

Historic Return on Equity for Inhibrx Biosciences (INBX) over the last 1 years, with Sep 2025 value amounting to -2.94%.

  • Inhibrx Biosciences' Return on Equity fell 1121.00% to -2.94% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.94%, marking a year-over-year decrease of 1121.00%. This contributed to the annual value of 19.06% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Inhibrx Biosciences' Return on Equity stood at -2.94%, which was down 46.53% from -2.01% recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Return on Equity ranged from a high of 15.11% in Q1 2025 and a low of -2.94% during Q3 2025.
  • Over the past 2 years, Inhibrx Biosciences' median Return on Equity value was 8.26% (recorded in 2024), while the average stood at 5.85%.
  • Data for Inhibrx Biosciences' Return on Equity shows a maximum YoY tumbled of 1,121bps (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Inhibrx Biosciences' Return on Equity stood at 10.82% in 2024, then plummeted by 1,121bps to -2.94% in 2025.
  • Its last three reported values are -2.94% in Q3 2025, -2.01% for Q2 2025, and 15.11% during Q1 2025.